Impact and prevention of severe exacerbations of COPD: a review of the evidence
David MG Halpin,1 Marc Miravitlles,2 Norbert Metzdorf,3 Bartolomé Celli4 1Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK; 2Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spai...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-10-01
|
| Series: | International Journal of COPD |
| Subjects: | |
| Online Access: | https://www.dovepress.com/impact-and-prevention-of-severe-exacerbations-of-copd-a-review-of-the--peer-reviewed-article-COPD |
| _version_ | 1819009424418668544 |
|---|---|
| author | Halpin DMG Miravitlles M Metzdorf N Celli B |
| author_facet | Halpin DMG Miravitlles M Metzdorf N Celli B |
| author_sort | Halpin DMG |
| collection | DOAJ |
| description | David MG Halpin,1 Marc Miravitlles,2 Norbert Metzdorf,3 Bartolomé Celli4 1Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK; 2Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 3Respiratory Medicine, Boehringer Ingelheim Pharma GmBH & Co KG, Ingelheim am Rhein, Germany; 4Pulmonary Division, Brigham and Women’s Hospital, Boston, MA, USA Abstract: Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical implications for patients and significant economic consequences for society. The prevalence and burden of severe COPD exacerbations remain high, despite recognition of the importance of exacerbation prevention and the availability of new treatment options. Severe COPD exacerbations are associated with high mortality, have negative impact on quality of life, are linked to cardiovascular complications, and are a significant burden on the health-care system. This review identified risk factors that contribute to the development of severe exacerbations, treatment options (bronchodilators, antibiotics, corticosteroids [CSs], oxygen therapy, and ventilator support) to manage severe exacerbations, and strategies to prevent readmission to hospital. Risk factors that are amenable to change have been highlighted. A number of bronchodilators have demonstrated successful reduction in risk of severe exacerbations, including long-acting muscarinic antagonist or long-acting β2-agonist mono- or combination therapies, in addition to vaccination, mucolytic and antibiotic therapy, and nonpharmacological interventions, such as pulmonary rehabilitation. Recognition of the importance of severe exacerbations is an essential step in improving outcomes for patients with COPD. Evidence-based approaches to prevent and manage severe exacerbations should be implemented as part of targeted strategies for disease management. Keywords: severe COPD exacerbations, hospitalization, prevention, treatment, bronchodilators, long-acting muscarinic antagonist |
| first_indexed | 2024-12-21T00:56:09Z |
| format | Article |
| id | doaj.art-3db278f858eb4d3bb1974914aa1f309d |
| institution | Directory Open Access Journal |
| issn | 1178-2005 |
| language | English |
| last_indexed | 2024-12-21T00:56:09Z |
| publishDate | 2017-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of COPD |
| spelling | doaj.art-3db278f858eb4d3bb1974914aa1f309d2022-12-21T19:21:18ZengDove Medical PressInternational Journal of COPD1178-20052017-10-01Volume 122891290835049Impact and prevention of severe exacerbations of COPD: a review of the evidenceHalpin DMGMiravitlles MMetzdorf NCelli BDavid MG Halpin,1 Marc Miravitlles,2 Norbert Metzdorf,3 Bartolomé Celli4 1Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK; 2Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 3Respiratory Medicine, Boehringer Ingelheim Pharma GmBH & Co KG, Ingelheim am Rhein, Germany; 4Pulmonary Division, Brigham and Women’s Hospital, Boston, MA, USA Abstract: Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical implications for patients and significant economic consequences for society. The prevalence and burden of severe COPD exacerbations remain high, despite recognition of the importance of exacerbation prevention and the availability of new treatment options. Severe COPD exacerbations are associated with high mortality, have negative impact on quality of life, are linked to cardiovascular complications, and are a significant burden on the health-care system. This review identified risk factors that contribute to the development of severe exacerbations, treatment options (bronchodilators, antibiotics, corticosteroids [CSs], oxygen therapy, and ventilator support) to manage severe exacerbations, and strategies to prevent readmission to hospital. Risk factors that are amenable to change have been highlighted. A number of bronchodilators have demonstrated successful reduction in risk of severe exacerbations, including long-acting muscarinic antagonist or long-acting β2-agonist mono- or combination therapies, in addition to vaccination, mucolytic and antibiotic therapy, and nonpharmacological interventions, such as pulmonary rehabilitation. Recognition of the importance of severe exacerbations is an essential step in improving outcomes for patients with COPD. Evidence-based approaches to prevent and manage severe exacerbations should be implemented as part of targeted strategies for disease management. Keywords: severe COPD exacerbations, hospitalization, prevention, treatment, bronchodilators, long-acting muscarinic antagonisthttps://www.dovepress.com/impact-and-prevention-of-severe-exacerbations-of-copd-a-review-of-the--peer-reviewed-article-COPDsevere COPD exacerbationshospitalizationpreventiontreatmentbronchodilatorslong-acting muscarinic antagonist |
| spellingShingle | Halpin DMG Miravitlles M Metzdorf N Celli B Impact and prevention of severe exacerbations of COPD: a review of the evidence International Journal of COPD severe COPD exacerbations hospitalization prevention treatment bronchodilators long-acting muscarinic antagonist |
| title | Impact and prevention of severe exacerbations of COPD: a review of the evidence |
| title_full | Impact and prevention of severe exacerbations of COPD: a review of the evidence |
| title_fullStr | Impact and prevention of severe exacerbations of COPD: a review of the evidence |
| title_full_unstemmed | Impact and prevention of severe exacerbations of COPD: a review of the evidence |
| title_short | Impact and prevention of severe exacerbations of COPD: a review of the evidence |
| title_sort | impact and prevention of severe exacerbations of copd a review of the evidence |
| topic | severe COPD exacerbations hospitalization prevention treatment bronchodilators long-acting muscarinic antagonist |
| url | https://www.dovepress.com/impact-and-prevention-of-severe-exacerbations-of-copd-a-review-of-the--peer-reviewed-article-COPD |
| work_keys_str_mv | AT halpindmg impactandpreventionofsevereexacerbationsofcopdareviewoftheevidence AT miravitllesm impactandpreventionofsevereexacerbationsofcopdareviewoftheevidence AT metzdorfn impactandpreventionofsevereexacerbationsofcopdareviewoftheevidence AT cellib impactandpreventionofsevereexacerbationsofcopdareviewoftheevidence |